ArticleACG case reports journal2024

Immediate Infusion Reaction to Intravenous Risankizumab-rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-rzaa.

David Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.